Pharmaceutical Cold Chain Logistics Market - 2025-2033

March 2026 | 243 pages | ID: PA1E8DEC631EEN
DataM Intelligence

Abstracts

The Pharmaceutical Cold Chain Logistics Market was valued at US$ 22.75 Billion in 2025 and is anticipated to reach US$ 44.1 Billion by 2033, at a CAGR of 0.0912 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Pharmaceutical Cold Chain Logistics Market.

This report delivers a comprehensive overview of the Pharmaceutical Cold Chain Logistics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Cold Chain Logistics Market. The Pharmaceutical Cold Chain Logistics Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

Pharmaceutical Cold Chain Logistics Market Scope:

Key Players

• Cardinal Health

Major Highlights

This report delivers a comprehensive overview of the Pharmaceutical Cold Chain Logistics Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Cold Chain Logistics Market. The Pharmaceutical Cold Chain Logistics Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections

4. SNIPPET BY PRODUCT TYPE

4.1. Snippet by Service Type
4.2. Snippet by Temperature Range
4.3. Snippet by Mode of Delivery
4.4. Snippet by End-User
4.5. Snippet by Region

5. DYNAMICS

5.1. Impacting Factors
  5.1.1. Drivers
    5.1.1.1. Rising Advancements in Cold Chain Technology
    5.1.1.2. Virtual Control Towers and Real-Time Tracking
    5.1.1.3. XX
  5.1.2. Restraints
    5.1.2.1. Regulatory Challenges
    5.1.2.2. Complications in Pharmaceutical Cold Chain Logistics
    5.1.2.3. XX
  5.1.3. Opportunity
    5.1.3.1. Integration with AI in Pharmaceutical Cold Chain Logistics
    5.1.3.2. XX
  5.1.4. Impact Analysis

6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

6.1. Market Leaders and Pioneers
  6.1.1. Emerging Pioneers and Prominent Players
  6.1.2. Established Leaders with the Largest Marketing Brand
  6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. Regulatory and Reimbursement Landscape
  6.3.1. North America
  6.3.2. Europe
  6.3.3. Asia Pacific
  6.3.4. South America
  6.3.5. Middle East & Africa
6.4. Porter’s Five Forces Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Unmet Needs and Gaps
6.9. Recommended Strategies for Market Entry and Expansion
6.10. Pricing Analysis and Price Dynamics

7. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  7.1.2. Market Attractiveness Index, By Product Type
7.2. Vaccines*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Biopharmaceuticals
7.4. Drugs and Medicines

8. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY SERVICE TYPE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  8.1.2. Market Attractiveness Index, By Service Type
8.2. Storage*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Transportation
8.4. Packaging
8.5. Others

9. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE RANGE

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  9.1.2. Market Attractiveness Index, By Temperature Range
9.2. Frozen (Below -20°C) *
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Refrigerated (2°C to 8°C)
9.4. Ambient (15°C to 25°C)
9.5. Cryogenic (-150°C)

10. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF DELIVERY

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  10.1.2. Market Attractiveness Index, By Mode of Delivery
10.2. Last-Mile Delivery *
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Hubs-to-Distributor

11. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY END-USER

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.1.2. Market Attractiveness Index, By End-User
11.2. Pharmaceutical and Biopharmaceutical Companies*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Biotechnology Companies
11.4. Hospitals and Healthcare Facilities
11.5. Others

12. PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

13. INTRODUCTION

13.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  13.1.1. Market Attractiveness Index, By Region
13.2. North America
  13.2.1. Introduction
  13.2.2. Key Region-Specific Dynamics
  13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.2.8.1. U.S.
    13.2.8.2. Canada
    13.2.8.3. Mexico
13.3. Europe
  13.3.1. Introduction
  13.3.2. Key Region-Specific Dynamics
  13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.3.8.1. Germany
    13.3.8.2. UK
    13.3.8.3. France
    13.3.8.4. Spain
    13.3.8.5. Italy
    13.3.8.6. Rest of Europe
13.4. Asia-Pacific
  13.4.1. Introduction
  13.4.2. Key Region-Specific Dynamics
  13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.4.8.1. China
    13.4.8.2. India
    13.4.8.3. Japan
    13.4.8.4. South Korea
    13.4.8.5. Rest of Asia-Pacific
13.5. South America
  13.5.1. Introduction
  13.5.2. Key Region-Specific Dynamics
  13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.5.8.1. Brazil
    13.5.8.2. Argentina
    13.5.8.3. Rest of South America
13.6. Middle East and Africa
  13.6.1. Introduction
  13.6.2. Key Region-Specific Dynamics
  13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Temperature Range
  13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  13.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

14. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

15. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS

15.1. Market Share Analysis and Positioning Matrix
15.2. Strategic Partnerships, Mergers & Acquisitions
15.3. Key Developments in Product Portfolios and Innovations
15.4. Company Benchmarking

16. COMPANY PROFILES

16.1. Cardinal Health*
  16.1.1. Company Overview
  16.1.2. Product Portfolio
    16.1.2.1. Product Description
    16.1.2.2. Product Key Performance Indicators (KPIs)

17. FINANCIAL OVERVIEW

17.1. Company Revenue
  17.1.1. Geographical Revenue Shares
    17.1.1.1. Revenue Forecasts
  17.1.2. Key Developments
    17.1.2.1. Mergers & Acquisitions
    17.1.2.2. Key Product Development Activities
    17.1.2.3. Regulatory Approvals, etc.
  17.1.3. SWOT Analysis
17.2. AmerisourceBergen Corporation
17.3. Envirotainer AB
17.4. FedEx
17.5. United Parcel Service of America, Inc.
17.6. Thermo King
17.7. Sonoco ThermoSafe
17.8. B Medical Systems India Private Limited
17.9. DoKaSch TEMPERATURE SOLUTIONS GmbH
17.10. Nordic Cold Chain SolutionsLIST NOT EXHAUSTIVE

18. ASSUMPTION AND RESEARCH METHODOLOGY

18.1. Data Collection Methods
18.2. Data Triangulation
18.3. Forecasting Techniques
18.4. Data Verification and Validation

19. APPENDIX

19.1. About Us and Services
19.2. Contact Us